BKIDC-1553
Product Specifications
UNSPSC Description
BKIDC-1553 is an orally active antiglycolytic agent and a bumped kinase inhibitor derived compound with a predicted ~17 h half-life in human. BKIDC-1553 inhibits CYP2C8 and Angiotensin Converting Enzyme and can be used for cancer research[1].
Target Antigen
Angiotensin-converting Enzyme (ACE)
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
Cancer-Kinase/protease
Field of Research
Cancer; Cardiovascular Disease
Assay Protocol
https://www.medchemexpress.com/bkidc-1553.html
Solubility
DMSO : 20 mg/mL (ultrasonic)
Smiles
OC(C)(CN1N=C(C2=C1N=CN=C2N)C3=CC4=C(C=C(C=C4)OC5CC5)C=C3)C
Molecular Weight
389.45
References & Citations
[1]Uo T, et al. A Compound that Inhibits Glycolysis in Prostate Cancer Controls Growth of Advanced Prostate Cancer. bioRxiv [Preprint]. 2024 Feb 13:2023.07.01.547355.
Shipping Conditions
Room Temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-163438/BKIDC-1553-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-163438/BKIDC-1553-SDS-MedChemExpress.pdf
Clinical Information
No Development Reported
CAS Number
1951431-34-7
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
